NZ727388A - Stabilized desmopressin - Google Patents

Stabilized desmopressin Download PDF

Info

Publication number
NZ727388A
NZ727388A NZ727388A NZ72738815A NZ727388A NZ 727388 A NZ727388 A NZ 727388A NZ 727388 A NZ727388 A NZ 727388A NZ 72738815 A NZ72738815 A NZ 72738815A NZ 727388 A NZ727388 A NZ 727388A
Authority
NZ
New Zealand
Prior art keywords
desmopressin
gum
pharmaceutical composition
acceptable salt
pharmaceutically acceptable
Prior art date
Application number
NZ727388A
Other languages
English (en)
Inventor
Bong Sang Lee
Su-Jun Park
Jiyeong Han
Myeongcheol Kil
Min Seop Kim
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ727388(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NZ727388A publication Critical patent/NZ727388A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ727388A 2014-06-16 2015-06-15 Stabilized desmopressin NZ727388A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물
PCT/EP2015/063347 WO2015193246A1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Publications (1)

Publication Number Publication Date
NZ727388A true NZ727388A (en) 2021-07-30

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ727388A NZ727388A (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Country Status (33)

Country Link
US (1) US20170128521A1 (enExample)
EP (1) EP3154516B1 (enExample)
JP (1) JP6615130B2 (enExample)
KR (2) KR20150144209A (enExample)
CN (1) CN106456706B (enExample)
AR (1) AR100850A1 (enExample)
AU (1) AU2015276247C1 (enExample)
CA (1) CA2951768C (enExample)
CL (1) CL2016003219A1 (enExample)
CO (1) CO2017000354A2 (enExample)
DK (1) DK3154516T3 (enExample)
EA (1) EA032834B1 (enExample)
ES (1) ES2751600T3 (enExample)
HR (1) HRP20191746T1 (enExample)
HU (1) HUE045395T2 (enExample)
IL (1) IL249538A0 (enExample)
JO (1) JO3500B1 (enExample)
LT (1) LT3154516T (enExample)
MX (1) MX374540B (enExample)
MY (1) MY182781A (enExample)
NZ (1) NZ727388A (enExample)
PH (1) PH12016502527A1 (enExample)
PL (1) PL3154516T3 (enExample)
PT (1) PT3154516T (enExample)
RS (1) RS59449B1 (enExample)
SA (1) SA516380492B1 (enExample)
SG (2) SG11201609374YA (enExample)
SI (1) SI3154516T1 (enExample)
TN (1) TN2016000561A1 (enExample)
TW (1) TWI670070B (enExample)
UA (1) UA119776C2 (enExample)
WO (1) WO2015193246A1 (enExample)
ZA (1) ZA201608020B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003233118B8 (en) * 2002-05-07 2009-07-30 Ferring Bv Desmopressin in an orodispersible dosage form
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release

Also Published As

Publication number Publication date
MY182781A (en) 2021-02-05
TW201605464A (zh) 2016-02-16
ES2751600T3 (es) 2020-04-01
BR112016029417A8 (pt) 2021-06-29
DK3154516T3 (da) 2019-09-23
CA2951768C (en) 2022-08-30
AU2015276247B2 (en) 2019-09-12
AR100850A1 (es) 2016-11-02
AU2015276247A1 (en) 2017-02-02
IL249538A0 (en) 2017-02-28
US20170128521A1 (en) 2017-05-11
HUE045395T2 (hu) 2019-12-30
EP3154516B1 (en) 2019-09-04
UA119776C2 (uk) 2019-08-12
CA2951768A1 (en) 2015-12-23
SI3154516T1 (sl) 2019-11-29
JP6615130B2 (ja) 2019-12-04
CN106456706A (zh) 2017-02-22
EA032834B1 (ru) 2019-07-31
LT3154516T (lt) 2019-10-25
PL3154516T3 (pl) 2020-08-10
RS59449B1 (sr) 2019-11-29
CN106456706B (zh) 2020-07-14
PH12016502527B1 (en) 2017-04-10
KR20170020450A (ko) 2017-02-22
BR112016029417A2 (pt) 2017-08-22
SA516380492B1 (ar) 2021-02-03
TWI670070B (zh) 2019-09-01
EA201692556A1 (ru) 2017-04-28
HRP20191746T1 (hr) 2019-12-27
EP3154516A1 (en) 2017-04-19
MX374540B (es) 2025-03-06
TN2016000561A1 (en) 2018-04-04
JP2017523955A (ja) 2017-08-24
CL2016003219A1 (es) 2017-06-30
SG11201609374YA (en) 2017-01-27
WO2015193246A1 (en) 2015-12-23
JO3500B1 (ar) 2020-07-05
MX2016016635A (es) 2017-06-06
KR102360656B1 (ko) 2022-02-09
KR20150144209A (ko) 2015-12-24
ZA201608020B (en) 2020-05-27
PH12016502527A1 (en) 2017-04-10
CO2017000354A2 (es) 2017-03-31
AU2015276247C1 (en) 2020-02-06
SG10201811139UA (en) 2019-01-30
PT3154516T (pt) 2019-12-05

Similar Documents

Publication Publication Date Title
US20230346881A1 (en) Stable Formulations of Linaclotide
US20250144112A1 (en) Suspension for oral administration comprising amorphous tolvaptan
EP2982367A1 (en) Pharmaceutical composition for parenteral administration, containing donepezil
CN112220748B (zh) 地氯雷他定口服液制剂及其制备方法
US20130012454A1 (en) Orally Disintegrating Compositions of Linaclotide
CN107530342A (zh) 口服给药用医药组合物
CN102784382A (zh) 一种阿加曲班药物组合物及其制备方法和应用
NZ727388A (en) Stabilized desmopressin
US20210369624A1 (en) Solid oral dosage form having excellent dissolution properties
CN113950324A (zh) 微型软胶囊萘普生组合物
US20140107130A1 (en) Oral Solution Formulations of Aripiprazole
HK1235295B (en) Stabilized desmopressin
HK1235295A1 (en) Stabilized desmopressin
WO2015073967A1 (en) Novel metabolites of vanoxerine compounds for the treatment of dopaminergic diseases
BR112016029417B1 (pt) Composição farmacêutica na forma de uma película de desintegração oral, seu método de preparação, e uso de gomas para aumentar sua estabilidade
WO2025108313A1 (zh) 包含egfr抑制剂的药物组合物
CN115400123A (zh) 一种替扎尼定液体制剂及其用途
HK1216620B (en) Suspension for oral administration comprising amorphous tolvaptan
JP2011153154A5 (enExample)

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUN 2023 BY IPAN GMBH

Effective date: 20220601

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUN 2024 BY IPAN GMBH

Effective date: 20230601

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUN 2025 BY IPAN GMBH

Effective date: 20240603

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 JUN 2026 BY IPAN GMBH

Effective date: 20250602